Factors associated with diagnosis of stages I and II lung cancer: a multivariate analysis

Autores

DOI:

https://doi.org/10.11606/s1518-8787.2021055003345

Palavras-chave:

Lung Neoplasms, diagnosis, Early Detection of Cancer, Survival Analysis, Socioeconomic Factors, Healthcare Disparities

Resumo

OBJECTIVE To present the overall survival rate for lung cancer and identify the factors associated with early diagnosis of stage I and II lung cancer. METHODS This is a retrospective cohort study including individuals diagnosed with lung cancer, from January 2009 to December 2017, according to the cancer registry at UMass Memorial Medical Center. Five-year overall survival and its associated factors were identified by Kaplan–Meier curves and Cox’s proportional hazards model. Factors associated with diagnosing clinical stage I and II lung cancer were identified by bivariate and multivariate backward stepwise logistic regression (Log-likelihood ratio (LR)) at 95% confidence interval (CI). RESULTS The study was conducted with data on 2730 individuals aged 67.9 years on average, 51.5% of whom female, 92.3% white, and 6.6% never smoked. Five-year overall survival was 21%. Individuals diagnosed with early-stage disease had a 43% five-year survival rate compared to 8% for those diagnosed at late stages. Stage at diagnosis was the main factor associated with overall survival [HR = 4.08 (95%CI: 3.62–4.59)]. Factors associated with early diagnosis included patients older than 68 years [OR = 1.23 (95%CI: 1.04–1.45)], of the female gender [OR = 1.47 (95%CI: 1.24–1.73)], white [OR = 1.63 (95%CI: 1.16–2.30)], and never-smokers [OR = 1.37 (95%CI: 1.01–1.86)]; as well as tumors affecting the upper lobe [OR = 1.46 (95%CI: 1.24–1.73)]; adenocarcinoma [OR = 1.43 (95%CI: 1.21–1.69)]; and diagnosis after 2014 [OR = 1.61 (95%CI: 1.37–1.90)]. CONCLUSIONS Stage at diagnosis was the most decisive predictor for survival. Non-white and male individuals were more likely to be diagnosed at a late stage. Thus, promoting lung cancer early diagnosis by improving access to health care is vital to enhance overall survival for individuals with lung cancer.

Referências

World Health Organization. Cancer. Geneva: WHO; 2021 [cited 2021 Apr 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. https://doi.org/10.3322/caac.21654

American Cancer Society, Cancer Statistics Center. Lung and bronchus statistics. Atlanta, GA; 2020 [cited 2020 Mar 25]. Available from: https://cancerstatisticscenter.cancer.org/#!/cancer-site/Lung%20and%20bronchus

Lin JJ, Mhango G, Wall MM, Lurslurchachai L, Bond KT, Nelson JE, et al. Cultural factors associated with racial disparities in lung cancer care. Ann Am Thorac Soc. 2014;11(4):489-95. https://doi.org/10.1513/AnnalsATS.201402-055OC

Weksler B, Kosinski AS, Burfeind WR, Silvestry SC, Sullivan J, D'Amico TA. Racial and ethnic differences in lung cancer surgical stage: an STS database study. Thorac Cardiovasc Surg. 2015;63(7):538-43. https://10.1055/s-0035-1546295

Wisnivesky JP, Halm EA, Bonomi M, Smith C, Mhango G, Bagiella E. Postoperative radiotherapy for elderly patients with stage III lung cancer. cancer. 2012;118(18):4478-85. https://doi.org/10.1002/cncr.26585

Andersen RM, Davidson PL, Baumeister SE. Improving access to care. In: Kominsky GF. Changing the U.S. health care system: key issues in health services policy and management. 4. ed. San Francisco, CA: Jossey-Bass; 2014. p.33-65.

Crawford SM, Sauerzapf V, Haynes R, Zhao H, Forman D, Jones AP. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer. 2009;101(6):897-901. https://doi.org/10.1038/sj.bjc.6605257

Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165-73. https://doi.org/10.1001/jama.2014.17322

Watson JM, Logan HL, Tomar SL, Sandow P. Factors associated with early-stage diagnosis of oral and pharyngeal cancer. Community Dent Oral Epidemiol. 2009;37(4):333-41. https://doi.org/10.1111/j.1600-0528.2009.00470.x

Morris CR, Sands MT, Smith LH. Ovarian cancer: predictors of early-stage diagnosis. Cancer Causes Control. 2010;21(8):1203-11. https://doi.org/10.1007/s10552-010-9547-0

Manasanch EE, Smith JK, Bodnari A, McKinney J, Gray C, McDade TP, et al. Tumor registry versus physician medical record review: a direct comparison of patients with pancreatic neuroendocrine tumors. J Oncol Pract. 2011;7(2):111-6. https://doi.org/10.1200/JOP.2010.000097

Morère JF, Viguier J, Touboul C, Pivot X, Blay JY, Coscaas Y, et al. Lung cancer risks, beliefs and healthcare access among the underprivileged. Eur J Cancer Prev. 2015;24 Suppl:S82-6. https://doi.org/10.1097/CEJ.0000000000000143

American College of Surgeons, Comission on Cancer. FORDS -Facility Oncology Registry Data Standards: revised for 2015. Chicago, ILL; 2015 [cited 2020 Mar 25]. Available from: https://www.facs.org/-/media/files/quality-programs/cancer/coc/fords/fords-2015.ashx

United States Census Bureau. Decennial Census of Population and Housing. Washington, DC; 2010 [cited 2019 July 8]. Available from: https://www.census.gov/programs-surveys/decennial-census/data/datasets.html

Chen T, Zhou F, Jiang W,Mao R, Zheng H, Qin L, et al. Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patients. J Thorac Dis. 2019;11(6):2251-66. https://doi.org/10.21037/jtd.2019.06.24

Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6(5):1507-13. https://doi.org/10.3892/ol.2013.1566

Scaglia NC, Chatkin JM, Pinto JA, Tsukazan MTR, Wagner MB, Saldanha AF. Role of gender in the survival of surgical patients with nonsmall cell lung cancer. Ann Thorac Med. 2013;8(3):142-7. https://doi.org/10.4103/1817-1737.114297

Visbal AL, Williams BA, Nichols FC 3rd, Marks RS, Jett JR, Aubry MS, et al. Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg. 2004;78(1):209-215. https://doi.org/10.1016/j.athoracsur.2003.11.021

Lohse T, Rohrmann S, Bopp M, Faeh D. Heavy smoking is more strongly associated with general unhealthy lifestyle than obesity and underweight. PLoS One. 2016;11(2):e0148563. https://doi.org/10.1371/journal.pone.0148563

Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med (Lond). 2018;18 Suppl 2:s41-6. https://doi.org/10.7861/clinmedicine.18-2-s41

Jones CC, Mercaldo SF, Blume JD, Blot WJ, Grogan EL, Aldrich MC, et al. racial disparities in lung cancer survival: the contribution of stage, treatment, and ancestry. J Thorac Oncol. 2018;13(10):1464-73. https://doi.org/10.1016/j.jtho.2018.05.032

Adamson BJS, Cohen AB, Estevez M,Magee K, Williams E, Gross CP, et al. Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment. J Clin Oncol. 2019;37(18 suppl):LBA1-LBA1. https://doi.org/10.1200/JCO.2019.37.18_suppl.LBA1

University of Washington, Institute for Health Metrics and Evaluation. US County Profile: Worcester County, Massachusetts. Seattle, WA: IHME; 2016 [cited 2020 April 15]. Available from: http://www.healthdata.org/sites/default/files/files/county_profiles/US/2015/County_Report_Worcester_County_Massachusetts.pdf

Wolf A, Alpert N, Tran BV, Liu B, Flores R, Taioli E. Persistence of racial disparities in early-stage lung cancer treatment. J Thorac Cardiovasc Surg. 2019;157(4):1670-9.e4. https://doi.org/10.1016/j.jtcvs.2018.11.108

Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198-205. https://doi.org/10.1056/NEJM199910143411606

Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106-13. https://doi.org/10.1001/jama.287.16.2106

Forrest LF, Adams J, Wareham H, Rubin G, White M. Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis. PLoS Med. 2013;10(2):e1001376. https://doi.org/10.1371/journal.pmed.1001376

Li CC, Matthews AK, Rywant MM, Hallgren E, Shah RC. Racial disparities in eligibility for low-dose computed tomography lung cancer screening among older adults with a history of smoking. Innov Aging. 2018;2 Suppl 1:750. https://doi.org/10.1093/geroni/igy023.2769

Thompson AE, Anisimowicz Y, Miedema B, Hogg W, Wodchis WP, Aubrey-Bassler K. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38. https://doi.org/10.1186/s12875-016-0440-0

Publicado

2021-12-17

Edição

Seção

Artigos Originais

Como Citar

Emmerick, I. C. M., Singh, A. ., Powers, M., Lou, F., Lin, P., Maxfield, M., & Uy, K. (2021). Factors associated with diagnosis of stages I and II lung cancer: a multivariate analysis. Revista De Saúde Pública, 55, 112. https://doi.org/10.11606/s1518-8787.2021055003345